Invacare (IVC) Stock Price, News & Analysis

Company Overview

Invacare Corp. engages in the manufacture and distribution of medical equipment used in non-acute care settings. It focuses on medical device solutions for congenital, acquired, and degenerative ailments. The firm operates through the following segments: North America and Europe. The company was founded by Aaron Malachi Mixon III in 1979 and is headquartered in Elyria, OH.

Key Stats

• Today's Range: N/A
• 50-Day Range: $0.35 to $0.74
• 52-Week Range: N/A
• Volume: 33,301 shs
• Average Volume: 240,305 shs
• Market Capitalization: $20.01 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

Invacare Stock Analysis - MarketRank™

Invacare scored higher than 12% of companies evaluated by MarketBeat, and ranked 892nd out of 940 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: N/A
• Analyst Rating: N/A

Consensus Rating

There is not enough analysis data for Invacare.

Earnings and Valuation

• Score: 0.6 / 5
• Proj. Earnings Growth: Growing

Earnings Growth

Earnings for Invacare are expected to grow in the coming year, from ($2.76) to ($1.59) per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of Invacare is -0.24, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of Invacare is -0.24, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Short Interest

• Score: N/A
• Short Interest Level: N/A

Short Interest

There is no current short interest data available for IVC.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Invacare does not currently pay a dividend.

Dividend Growth

Invacare does not have a long track record of dividend growth.

Sustainability and ESG

• Score: 4.5 / 5
• Environmental Score: -0.81

Short Interest

There is no current short interest data available for IVC.

News and Social Media

• Score: 0.6 / 5
• News Sentiment: N/A

Search Interest

1 people have searched for IVC on MarketBeat in the last 30 days.

Company Ownership

• Score: 0.8 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Invacare insiders have not sold or bought any company stock.

Percentage Held by Insiders

Only 6.90% of the stock of Invacare is held by insiders.

Percentage Held by Institutions

59.87% of the stock of Invacare is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

IVC Stock Analysis - Frequently Asked Questions

How were Invacare's earnings last quarter?

Invacare Co. (NYSE:IVC) announced its quarterly earnings data on Wednesday, October, 27th. The health services provider reported ($0.12) EPS for the quarter, beating the consensus estimate of ($0.20) by $0.08. The health services provider had revenue of $224.20 million for the quarter, compared to the consensus estimate of $222.27 million. Invacare had a negative trailing twelve-month return on equity of 37.76% and a negative net margin of 9.99%.

What other stocks do shareholders of Invacare own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Invacare investors own include Pfizer (PFE), Intel (INTC), Exxon Mobil (XOM), Micron Technology (MU), Occidental Petroleum (OXY), Devon Energy (DVN) and Global Blood Therapeutics (GBT).

Company Calendar

• Last Earnings: 10/27/2021
• Today: 7/15/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NYSE
• Sector: Medical
• Industry: Surgical appliances & supplies
• Sub-Industry: Health Care Equipment
• Current Symbol: NYSE:IVC
• CIK: 742112
• Web: www.invacare.com
• Phone: (440) 329-6000
• Fax: 877-619-7996
• Employees: 3,000
• Year Founded: 1885

Profitability

• EPS (Trailing Twelve Months): ($2.18)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -$45.56 million
• Net Margins: -9.99%
• Pretax Margin: -9.38%
• Return on Equity: -37.76%
• Return on Assets: -7.18%

Debt

• Debt-to-Equity Ratio: 4.82
• Current Ratio: 1.32
• Quick Ratio: 0.78

Sales & Book Value

• Annual Sales: $872.46 million
• Price / Sales: 0.00
• Cash Flow: N/A
• Price / Cash Flow: 0.77
• Book Value: $5.54 per share
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 37,760,000
• Free Float: 35,153,000
• Market Cap: $20.01 million
• Optionable: Optionable
• Beta: 0.38